Eva Kubrova

501 total citations
20 papers, 319 citations indexed

About

Eva Kubrova is a scholar working on Pharmacology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Eva Kubrova has authored 20 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Surgery and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Eva Kubrova's work include Musculoskeletal pain and rehabilitation (7 papers), Mesenchymal stem cell research (5 papers) and Pain Management and Treatment (4 papers). Eva Kubrova is often cited by papers focused on Musculoskeletal pain and rehabilitation (7 papers), Mesenchymal stem cell research (5 papers) and Pain Management and Treatment (4 papers). Eva Kubrova collaborates with scholars based in United States, Czechia and Netherlands. Eva Kubrova's co-authors include Wenchun Qu, André J. van Wijnen, Ryan S. D’Souza, Amel Dudakovic, Christopher R. Paradise, Roman Thaler, Zhen Wang, Larry J. Prokop, M. Hassan Murad and Sofía Jerez and has published in prestigious journals such as Gene, Journal of Cellular Physiology and Mayo Clinic Proceedings.

In The Last Decade

Eva Kubrova

18 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Kubrova United States 11 86 75 68 56 50 20 319
Jean‐Philippe Giot France 13 26 0.3× 11 0.1× 214 3.1× 39 0.7× 50 1.0× 42 397
Eui‐Suk Sung South Korea 13 130 1.5× 46 0.6× 131 1.9× 8 0.1× 60 1.2× 51 427
Megan Fracol United States 16 32 0.4× 27 0.4× 318 4.7× 17 0.3× 69 1.4× 48 554
Chien‐Jen Hsu Taiwan 13 110 1.3× 30 0.4× 363 5.3× 94 1.7× 58 1.2× 20 696
Haibo Mei China 13 56 0.7× 22 0.3× 201 3.0× 35 0.6× 4 0.1× 47 366
Joseph Purita United States 10 25 0.3× 61 0.8× 210 3.1× 27 0.5× 6 0.1× 24 469
Mansooreh Bagheri Iran 11 37 0.4× 105 1.4× 68 1.0× 4 0.1× 20 0.4× 20 420
Richard J. Zienowicz United States 13 33 0.4× 54 0.7× 489 7.2× 15 0.3× 25 0.5× 24 682
Frank Roesken Germany 11 114 1.3× 18 0.2× 86 1.3× 8 0.1× 10 0.2× 12 402
Tormod S. Westvik United States 14 169 2.0× 24 0.3× 324 4.8× 38 0.7× 6 0.1× 18 603

Countries citing papers authored by Eva Kubrova

Since Specialization
Citations

This map shows the geographic impact of Eva Kubrova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Kubrova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Kubrova more than expected).

Fields of papers citing papers by Eva Kubrova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Kubrova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Kubrova. The network helps show where Eva Kubrova may publish in the future.

Co-authorship network of co-authors of Eva Kubrova

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Kubrova. A scholar is included among the top collaborators of Eva Kubrova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Kubrova. Eva Kubrova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kubrova, Eva, et al.. (2025). Interventional Therapies to Treat Cancer Associated Pain. Current Treatment Options in Oncology. 26(7). 654–671. 1 indexed citations
2.
Kubrova, Eva, et al.. (2024). Complex Regional Pain Syndrome: Updates and Current Evidence. Current Physical Medicine and Rehabilitation Reports. 12(1). 50–70. 5 indexed citations
3.
Yan, Dan, Abba C. Zubair, Jeffrey A. Stone, et al.. (2024). CellKine clinical trial: first report from a phase 1 trial of allogeneic bone marrow–derived mesenchymal stem cells in subjects with painful lumbar facet joint arthropathy. PAIN Reports. 9(5). e1181–e1181. 2 indexed citations
4.
Kubrova, Eva, et al.. (2023). Physical functioning following spinal cord stimulation: a systematic review and meta-analysis. Regional Anesthesia & Pain Medicine. 48(6). 302–311. 20 indexed citations
5.
D’Souza, Ryan S., et al.. (2023). Treatment of pain in length-dependent peripheral neuropathy with the use of spinal cord stimulation: a systematic review. Pain Medicine. 24(Supplement_2). S24–S32. 4 indexed citations
6.
D’Souza, Ryan S., et al.. (2022). Dorsal Root Ganglion Stimulation for Lower Extremity Neuropathic Pain Syndromes: An Evidence-Based Literature Review. Advances in Therapy. 39(10). 4440–4473. 29 indexed citations
8.
Kubrova, Eva, et al.. (2022). Platelet Rich Plasma and Platelet-Related Products in the Treatment of Radiculopathy—A Systematic Review of the Literature. Biomedicines. 10(11). 2813–2813. 12 indexed citations
9.
Paradise, Christopher R., Sofía Jerez, Eva Kubrova, et al.. (2021). Brd4 is required for chondrocyte differentiation and endochondral ossification. Bone. 154. 116234–116234. 13 indexed citations
10.
Qu, Wenchun, Zhen Wang, Christine Hunt, et al.. (2021). The Effectiveness and Safety of Platelet-Rich Plasma for Chronic Wounds. Mayo Clinic Proceedings. 96(9). 2407–2417. 41 indexed citations
11.
Paradise, Christopher R., Eva Kubrova, Sofía Jerez, et al.. (2021). Multiple pharmacological inhibitors targeting the epigenetic suppressor enhancer of zeste homolog 2 (Ezh2) accelerate osteoblast differentiation. Bone. 150. 115993–115993. 35 indexed citations
12.
Qu, Wenchun, Zhen Wang, Joshua M. Hare, et al.. (2020). Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome. Stem Cells Translational Medicine. 9(9). 1007–1022. 75 indexed citations
13.
Kubrova, Eva, Sofía Jerez, Allan B. Dietz, et al.. (2020). Differences in Cytotoxicity of Lidocaine, Ropivacaine, and Bupivacaine on the Viability and Metabolic Activity of Human Adipose-Derived Mesenchymal Stem Cells. American Journal of Physical Medicine & Rehabilitation. 100(1). 82–91. 13 indexed citations
14.
Kubrova, Eva, Ryan S. D’Souza, Christine Hunt, et al.. (2020). Injectable Biologics. American Journal of Physical Medicine & Rehabilitation. 99(10). 950–960. 13 indexed citations
15.
Kubrova, Eva, André J. van Wijnen, & Wenchun Qu. (2020). Spine Disorders and Regenerative Rehabilitation. Current Physical Medicine and Rehabilitation Reports. 8(1). 30–36. 1 indexed citations
16.
Paradise, Christopher R., Eva Kubrova, Roman Thaler, et al.. (2019). The epigenetic reader Brd4 is required for osteoblast differentiation. Journal of Cellular Physiology. 235(6). 5293–5304. 22 indexed citations
17.
Kubrova, Eva, et al.. (2019). Exercise in the Aquatic Environment for Patients With Chronic Spinal Cord Injury and Invasive Appliances. American Journal of Physical Medicine & Rehabilitation. 99(2). 109–115.
18.
Kubrova, Eva, Wenchun Qu, Christopher R. Paradise, et al.. (2019). Hypothermia and nutrient deprivation alter viability of human adipose-derived mesenchymal stem cells. Gene. 722. 144058–144058. 11 indexed citations
19.
Kubrova, Eva, Tao Wu, Janet M. Denbeigh, et al.. (2019). Effect of Lidocaine on Viability and Gene Expression of Human Adipose–derived Mesenchymal Stem Cells: An in vitro Study. PM&R. 11(11). 1218–1227. 7 indexed citations
20.
Stiens, Steven A., et al.. (2017). Aquatic-Based Therapy in Spinal Cord Injury Rehabilitation: Effective Yet Underutilized. Current Physical Medicine and Rehabilitation Reports. 5(3). 108–112. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026